New York Approves Exagen Lupus Test | GenomeWeb

NEW YORK (GenomeWeb News) – Exagen Diagnostics today said that New York has approved its Avise SLE diagnostic, SLE-Systemic Lupus Erythematosus.

The Albuquerque, NM-based firm said that its Avise SLE brand is now available for lupus and connective tissue disease patients across the US. Exagen, which raised $5.3 million last month, runs its CLIA-certified laboratory in Vista, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.